In addition, FAIM2 is significantly differentially expressed across immune subtypes and molecular subtypes of most cancer types, which may demonstrate that FAIM2 is a promising diagnostic pan-cancer biomarker and is involved in immune regulation. The gene discussed is FAIM2; the disease is cancer.